Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 389

1.

Ketamine effects on default mode network activity and vigilance: A randomized, placebo-controlled crossover simultaneous fMRI/EEG study.

Zacharias N, Musso F, Müller F, Lammers F, Saleh A, London M, de Boer P, Winterer G.

Hum Brain Mapp. 2019 Sep 18. doi: 10.1002/hbm.24791. [Epub ahead of print]

PMID:
31532029
2.

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice.

Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monzón-Sandoval J, Ribe E, Winchester L, Webber C, Nevado A, Jacobs T, Austin N, Theunis C, Grauwen K, Daniela Ruiz E, Mudher A, Vicente-Rodriguez M, Parker CA, Simmons C, Cash D, Richardson J; NIMA Consortium , Jones DNC, Lovestone S, Gómez-Nicola D, Perry VH.

Brain. 2019 Aug 26. pii: awz241. doi: 10.1093/brain/awz241. [Epub ahead of print]

PMID:
31504240
3.

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.

Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W.

Transl Psychiatry. 2019 Sep 3;9(1):216. doi: 10.1038/s41398-019-0553-z.

4.

Successional Dynamics in the Gut Microbiome Determine the Success of Clostridium difficile Infection in Adult Pig Models.

Jurburg SD, Cornelissen JJBWJ, de Boer P, Smits MA, Rebel JMJ.

Front Cell Infect Microbiol. 2019 Aug 6;9:271. doi: 10.3389/fcimb.2019.00271. eCollection 2019.

5.

Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis.

van Wijhe M, de Boer PT, de Jong HJ, van Vliet H, Wallinga J, Postma MJ.

Vaccine. 2019 Sep 10;37(38):5698-5707. doi: 10.1016/j.vaccine.2019.07.097. Epub 2019 Aug 13.

6.

A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.

van den Ameele S, van Nuijs AL, Lai FY, Schuermans J, Verkerk R, van Diermen L, Coppens V, Fransen E, de Boer P, Timmers M, Sabbe B, Morrens M.

Bipolar Disord. 2019 Aug 9. doi: 10.1111/bdi.12814. [Epub ahead of print]

PMID:
31398273
7.

Prospective validation of craniocaudal tumour size on MR imaging compared to histoPAthology in patients with uterine cervical cancer: The MPAC study.

de Boer P, Spijkerboer AM, Bleeker MCG, van Lonkhuijzen LRCW, Monraats MA, Nederveen AJ, van de Vijver MJ, Kenter GG, Bel A, Rasch CRN, Stoker J, Stalpers LJA.

Clin Transl Radiat Oncol. 2019 Jun 15;18:9-15. doi: 10.1016/j.ctro.2019.06.004. eCollection 2019 Sep.

8.

Burden of Surgical Site Infections in The Netherlands: Cost analyses and Disability Adjusted Life Years.

Koek MBG, van der Kooi TII, Stigter FCA, de Boer PT, de Gier B, Hopmans TEM, de Greeff SC; burden of SSI study group.

J Hosp Infect. 2019 Jul 19. pii: S0195-6701(19)30304-4. doi: 10.1016/j.jhin.2019.07.010. [Epub ahead of print]

PMID:
31330166
9.

Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes.

Visser J, de Boer P, Crama KF, van Kesteren Z, Rasch CRN, Stalpers LJA, Bel A.

Radiat Oncol. 2019 Jul 12;14(1):126. doi: 10.1186/s13014-019-1322-0.

10.

Redesigning an International Orthopaedic CME Course: The Effects on Participant Engagement over 5 Years.

Bhashyam AR, van der Vliet QMJ, Houwert RM, Simmermacher RKJ, Brink P, de Boer P, Leenen LPH.

J Eur CME. 2019 Jun 26;8(1):1633193. doi: 10.1080/21614083.2019.1633193. eCollection 2019.

11.

Inflammatory biomarkers in Alzheimer's disease plasma.

Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease.

Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30.

12.

Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.

Perotin JM, Schofield JPR, Wilson SJ, Ward J, Brandsma J, Strazzeri F, Bansal A, Yang X, Rowe A, Corfield J, Lutter R, Shaw DE, Bakke PS, Caruso M, Dahlén B, Fowler SJ, Horváth I, Howarth P, Krug N, Montuschi P, Sanak M, Sandström T, Sun K, Pandis I, Auffray C, De Meulder B, Lefaudeux D, Riley JH, Sousa AR, Dahlen SE, Adcock IM, Chung KF, Sterk PJ, Skipp PJ, Collins JE, Davies DE, Djukanović R; U-BIOPRED Study Group; U-BIOPRED:.

Eur Respir J. 2019 Jun 27;53(6). pii: 1900453. doi: 10.1183/13993003.00453-2019. Print 2019 Jun. No abstract available.

PMID:
31023846
13.

Roles of the DedD Protein in Escherichia coli Cell Constriction.

Liu B, Hale CA, Persons L, Phillips-Mason PJ, de Boer PAJ.

J Bacteriol. 2019 Mar 26;201(8). pii: e00698-18. doi: 10.1128/JB.00698-18. Print 2019 Apr 15.

PMID:
30692172
14.

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.

Brooks S, Jacobs GE, de Boer P, Kent JM, Van Nueten L, van Amerongen G, Zuiker R, Kezic I, Luthringer R, van der Ark P, van Gerven JM, Drevets W.

J Psychopharmacol. 2019 Feb;33(2):202-209. doi: 10.1177/0269881118822258. Epub 2019 Jan 15.

PMID:
30644312
15.

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.

de Boer PT, van Lier A, de Melker H, van Wijck AJM, Wilschut JC, van Hoek AJ, Postma MJ.

BMC Med. 2018 Dec 6;16(1):228. doi: 10.1186/s12916-018-1213-5.

16.

State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis?

De Picker L, Ottoy J, Verhaeghe J, Deleye S, Wyffels L, Fransen E, Kosten L, Sabbe B, Coppens V, Timmers M, de Boer P, Van Nueten L, Op De Beeck K, Oberacher H, Vanhoenacker F, Ceyssens S, Stroobants S, Staelens S, Morrens M.

Brain Behav Immun. 2019 Mar;77:46-54. doi: 10.1016/j.bbi.2018.11.318. Epub 2018 Nov 29.

PMID:
30503836
17.

Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.

Niemegeers P, de Boer P, Schuermans J, Dumont GJH, Coppens V, Spittaels K, Claes S, Sabbe BGC, Morrens M.

J Affect Disord. 2019 Feb 15;245:356-363. doi: 10.1016/j.jad.2018.11.020. Epub 2018 Nov 6.

PMID:
30423462
18.

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants.

Timmers M, Ravenstijn P, Xi L, Triana-Baltzer G, Furey M, Van Hemelryck S, Biewenga J, Ceusters M, Bhattacharya A, van den Boer M, van Nueten L, de Boer P.

J Psychopharmacol. 2018 Dec;32(12):1341-1350. doi: 10.1177/0269881118800067. Epub 2018 Sep 27.

PMID:
30260294
19.

Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.

van der Ark PD, Golor G, van Nueten L, Nandy P, de Boer P.

J Psychopharmacol. 2018 Dec;32(12):1330-1340. doi: 10.1177/0269881118791521. Epub 2018 Sep 5.

PMID:
30182786
20.

Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network.

Mueller F, Musso F, London M, de Boer P, Zacharias N, Winterer G.

Neuroimage Clin. 2018 Jun 1;19:745-757. doi: 10.1016/j.nicl.2018.05.037. eCollection 2018.

Supplemental Content

Loading ...
Support Center